CN101248036B - 邻乙酰基水杨酸与碱性氨基酸的盐和甘氨酸的稳定的活性物质络合物 - Google Patents
邻乙酰基水杨酸与碱性氨基酸的盐和甘氨酸的稳定的活性物质络合物 Download PDFInfo
- Publication number
- CN101248036B CN101248036B CN200680019089.XA CN200680019089A CN101248036B CN 101248036 B CN101248036 B CN 101248036B CN 200680019089 A CN200680019089 A CN 200680019089A CN 101248036 B CN101248036 B CN 101248036B
- Authority
- CN
- China
- Prior art keywords
- active ingredient
- glycine
- acetylsalicylic acid
- ingredient complex
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/14—Acetic acid esters of monohydroxylic compounds
- C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
- C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
Abstract
Description
Claims (5)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005025283.4 | 2005-06-02 | ||
DE102005025283A DE102005025283A1 (de) | 2005-06-02 | 2005-06-02 | Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin |
PCT/EP2006/004799 WO2006128600A2 (de) | 2005-06-02 | 2006-05-20 | Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101248036A CN101248036A (zh) | 2008-08-20 |
CN101248036B true CN101248036B (zh) | 2016-03-16 |
Family
ID=36649662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200680019089.XA Expired - Fee Related CN101248036B (zh) | 2005-06-02 | 2006-05-20 | 邻乙酰基水杨酸与碱性氨基酸的盐和甘氨酸的稳定的活性物质络合物 |
Country Status (32)
Country | Link |
---|---|
US (1) | US8063243B2 (zh) |
EP (1) | EP1890994B1 (zh) |
JP (1) | JP2008542316A (zh) |
KR (1) | KR101347522B1 (zh) |
CN (1) | CN101248036B (zh) |
AR (1) | AR057341A1 (zh) |
AT (1) | ATE526974T1 (zh) |
AU (1) | AU2006254429B2 (zh) |
BR (1) | BRPI0610734A2 (zh) |
CA (1) | CA2610194C (zh) |
CR (1) | CR9556A (zh) |
CY (1) | CY1112185T1 (zh) |
DE (1) | DE102005025283A1 (zh) |
DK (1) | DK1890994T3 (zh) |
ES (1) | ES2373917T3 (zh) |
HR (1) | HRP20120003T1 (zh) |
IL (1) | IL187772A (zh) |
MA (1) | MA29604B1 (zh) |
MX (1) | MX2007014988A (zh) |
NO (1) | NO20076592L (zh) |
NZ (1) | NZ563871A (zh) |
PL (1) | PL1890994T3 (zh) |
PT (1) | PT1890994E (zh) |
RS (1) | RS52111B (zh) |
RU (1) | RU2433995C2 (zh) |
SG (1) | SG162744A1 (zh) |
SI (1) | SI1890994T1 (zh) |
TN (1) | TNSN07452A1 (zh) |
TW (1) | TWI374740B (zh) |
UA (1) | UA89827C2 (zh) |
WO (1) | WO2006128600A2 (zh) |
ZA (1) | ZA200710251B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008004386A1 (de) | 2008-01-14 | 2009-07-23 | Activaero Gmbh | Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen |
SG176880A1 (en) * | 2009-06-25 | 2012-02-28 | Tetra Sia | Novel acetylsalicylic acid salts |
BRPI1009600A2 (zh) * | 2009-06-25 | 2016-03-22 | Tetra S A | |
FR2950625B1 (fr) * | 2009-09-30 | 2016-12-02 | Holis Tech | Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue |
FR2965261B1 (fr) * | 2009-09-30 | 2012-10-26 | Holis Technologies | Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede |
TWI478715B (zh) * | 2010-12-03 | 2015-04-01 | Tetra Sia | 新穎乙醯柳酸鹽 |
RU2011132483A (ru) * | 2011-08-02 | 2013-02-10 | Елена Александровна Моренко | Биологически активный продукт для применения в ветеринарии и животноводстве, способ его получения и способы повышения выживаемости, стимуляции роста, иммуностимуляции и повышения общей неспецифической резистентности организма сельскохозяйственных животных |
CN102503845A (zh) * | 2011-09-28 | 2012-06-20 | 广州普星药业有限公司 | 一种dl-赖氨酸阿司匹林盐的制备方法及其应用 |
ITMI20121144A1 (it) * | 2012-06-28 | 2013-12-29 | Dipharma Francis Srl | Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo |
LV14963B (lv) | 2013-06-28 | 2015-10-20 | Tetra, Sia | Endoteliālās disfunkcijas korektors |
MX2018010049A (es) * | 2016-02-23 | 2018-11-09 | Merck Patent Gmbh | Particulas de glicina. |
US10882811B2 (en) | 2016-12-23 | 2021-01-05 | Aspiair Gmbh | Synthesis of lysine acetylsalicylate glycine particles |
CA3064012A1 (en) | 2017-05-30 | 2018-12-06 | Rhoshan Pharmaceuticals, Inc. | In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin) |
CN112592286B (zh) * | 2020-11-23 | 2024-02-02 | 蚌埠丰原医药科技发展有限公司 | 一种阿司匹林与碱性氨基酸的络合物的制备方法 |
WO2023131645A1 (en) | 2022-01-05 | 2023-07-13 | Aspiair Gmbh | Improved synthesis of lysine acetylsalicylate · glycine particles |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2051573A (en) * | 1979-07-06 | 1981-01-21 | Green Cross Corp | Acetylsalicylate powder composition |
EP0089198A2 (en) * | 1982-03-11 | 1983-09-21 | Dynatech Laboratories, Incorporated | Nontoxic aspirin-containing composition |
RU2203064C2 (ru) * | 2001-03-11 | 2003-04-27 | Каменев Виктор Федорович | Способ лечения аспириновой бронхиальной астмы |
WO2003059323A2 (de) * | 2002-01-18 | 2003-07-24 | Bayer Healthcare Ag | Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii |
CN1468209A (zh) * | 2000-07-18 | 2004-01-14 | 0-乙酰水杨酸与碱性氨基酸的稳定盐 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5665816A (en) * | 1979-11-01 | 1981-06-03 | Green Cross Corp:The | Acetylsalicylate pharmaceutical for injection |
CS247688B1 (cs) * | 1984-12-22 | 1987-01-15 | Evzen Kasafirek | Způsob výroby soli lysinu s kyselinou acetylsalicylovou |
EP0499142A3 (en) * | 1991-02-09 | 1993-05-05 | Hoechst Aktiengesellschaft | Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs |
FR2741534B1 (fr) * | 1995-11-23 | 1998-09-11 | Mazal Pharma | Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol |
JPH11222425A (ja) * | 1997-10-27 | 1999-08-17 | Ss Pharmaceut Co Ltd | 関節疾患治療用関節内投与製剤 |
DE102004025535A1 (de) * | 2004-05-25 | 2005-12-22 | Bayer Healthcare Ag | Kombination von Salzen der o-Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren |
-
2005
- 2005-06-02 DE DE102005025283A patent/DE102005025283A1/de not_active Withdrawn
-
2006
- 2006-05-20 EP EP06743005A patent/EP1890994B1/de active Active
- 2006-05-20 ES ES06743005T patent/ES2373917T3/es active Active
- 2006-05-20 US US11/921,339 patent/US8063243B2/en not_active Expired - Fee Related
- 2006-05-20 MX MX2007014988A patent/MX2007014988A/es active IP Right Grant
- 2006-05-20 AU AU2006254429A patent/AU2006254429B2/en not_active Ceased
- 2006-05-20 CN CN200680019089.XA patent/CN101248036B/zh not_active Expired - Fee Related
- 2006-05-20 NZ NZ563871A patent/NZ563871A/en not_active IP Right Cessation
- 2006-05-20 SI SI200631222T patent/SI1890994T1/sl unknown
- 2006-05-20 JP JP2008513970A patent/JP2008542316A/ja active Pending
- 2006-05-20 UA UAA200715004A patent/UA89827C2/ru unknown
- 2006-05-20 WO PCT/EP2006/004799 patent/WO2006128600A2/de active Application Filing
- 2006-05-20 AT AT06743005T patent/ATE526974T1/de active
- 2006-05-20 CA CA2610194A patent/CA2610194C/en not_active Expired - Fee Related
- 2006-05-20 KR KR1020077030689A patent/KR101347522B1/ko not_active IP Right Cessation
- 2006-05-20 RS RS20120002A patent/RS52111B/en unknown
- 2006-05-20 BR BRPI0610734-6A patent/BRPI0610734A2/pt not_active IP Right Cessation
- 2006-05-20 PL PL06743005T patent/PL1890994T3/pl unknown
- 2006-05-20 DK DK06743005.8T patent/DK1890994T3/da active
- 2006-05-20 SG SG201003850-3A patent/SG162744A1/en unknown
- 2006-05-20 PT PT06743005T patent/PT1890994E/pt unknown
- 2006-05-20 RU RU2007148709/04A patent/RU2433995C2/ru not_active IP Right Cessation
- 2006-05-31 AR ARP060102261A patent/AR057341A1/es unknown
- 2006-06-01 TW TW095119296A patent/TWI374740B/zh not_active IP Right Cessation
-
2007
- 2007-11-27 ZA ZA200710251A patent/ZA200710251B/xx unknown
- 2007-11-29 IL IL187772A patent/IL187772A/en not_active IP Right Cessation
- 2007-11-30 TN TNP2007000452A patent/TNSN07452A1/en unknown
- 2007-11-30 CR CR9556A patent/CR9556A/es not_active Application Discontinuation
- 2007-12-20 NO NO20076592A patent/NO20076592L/no not_active Application Discontinuation
- 2007-12-26 MA MA30515A patent/MA29604B1/fr unknown
-
2011
- 2011-12-30 CY CY20111101292T patent/CY1112185T1/el unknown
-
2012
- 2012-01-02 HR HR20120003T patent/HRP20120003T1/hr unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2051573A (en) * | 1979-07-06 | 1981-01-21 | Green Cross Corp | Acetylsalicylate powder composition |
EP0089198A2 (en) * | 1982-03-11 | 1983-09-21 | Dynatech Laboratories, Incorporated | Nontoxic aspirin-containing composition |
CN1468209A (zh) * | 2000-07-18 | 2004-01-14 | 0-乙酰水杨酸与碱性氨基酸的稳定盐 | |
RU2203064C2 (ru) * | 2001-03-11 | 2003-04-27 | Каменев Виктор Федорович | Способ лечения аспириновой бронхиальной астмы |
WO2003059323A2 (de) * | 2002-01-18 | 2003-07-24 | Bayer Healthcare Ag | Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii |
Non-Patent Citations (1)
Title |
---|
NAKAI T ET AL.Plasma cortisol levels in umbilical cord plasma and its change during the first two hours following delivery(Japanese).《FOLIA ENDOCRINOL.JAP.》.1976,第52卷(第5期),595-602. * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101248036B (zh) | 邻乙酰基水杨酸与碱性氨基酸的盐和甘氨酸的稳定的活性物质络合物 | |
TWI237024B (en) | A novel crystalline form of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process therefor | |
ES2212547T3 (es) | Nuevas formas de preparados galenicas del principio activo meloxicam. | |
US7449198B2 (en) | Stable salts of O-acetylsalicylic acid with basic amino acids | |
CN102459198A (zh) | 晶体 | |
JPS6236381A (ja) | グアニン誘導体結晶性一水和物、その製造方法及びそれを含む抗ウイルス剤 | |
AU2003235700B2 (en) | Stable salts of o-acetylsalicylic acid containing basic amino acids II | |
CN110022901A (zh) | 含有塞来昔布的药物组合物 | |
JP2004512355A (ja) | 新規な分散性および可溶性パラセタモールガレヌス製剤、その製法およびその用途 | |
JPS639493B2 (zh) | ||
WO2015154677A1 (zh) | 药物组合物及其应用 | |
CN111372572B (zh) | 包含丹皮酚和罗布麻宁的液体制剂 | |
CN104530121A (zh) | 磷酸肌酸瓜氨酸盐、其制备方法及用途 | |
JP2022517466A (ja) | 医学的障害の治療のための一酸化炭素プロドラッグ | |
JPH03184967A (ja) | フロセミド塩、それらの製造法、薬剤としての使用及びそれらを含有する製薬組成物 | |
CN108148097A (zh) | 含有吡啶的苯并咪唑类化合物钴配合物及其应用 | |
CN103720647A (zh) | 一种右旋布洛芬注射液组合物 | |
CN100560572C (zh) | 甘氨双唑酸的碱性氨基酸盐及其制备和用途 | |
CN108926530A (zh) | 一种具有高效混悬作用的对乙酰氨基酚液体制剂 | |
JPS6310721A (ja) | 制癌剤 | |
JPS639490B2 (zh) | ||
CN106995432A (zh) | 一种瑞普拉生无水合物晶型及其制备方法和用途 | |
JPS6344126B2 (zh) | ||
JPS638924B2 (zh) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1123543 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: BAYER SCHERING PHARMA AG Free format text: FORMER OWNER: BAYER HEALTHCARE AG Effective date: 20091127 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20091127 Address after: Berlin Applicant after: Bayer Schering Pharma AG Address before: Germany Leverkusen Applicant before: Bayer Healthcare AG |
|
ASS | Succession or assignment of patent right |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH Free format text: FORMER OWNER: BAYER PHARMACEUTICALS AG Effective date: 20130328 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Berlin Applicant after: BAYER PHARMA AG Address before: Berlin Applicant before: Bayer Schering Pharma AG |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: BAYER SCHERING PHARMA AG TO: BAYER PHARMACEUTICALS AG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130328 Address after: German Monheim Applicant after: BAYER INTELLECTUAL PROPERTY GmbH Address before: Berlin Applicant before: BAYER PHARMA AG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1123543 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160316 Termination date: 20170520 |